Literature DB >> 1327402

Chronic cerebrovascular insufficiency induces dementia-like deficits in aged rats.

J C de la Torre1, T Fortin, G A Park, K S Butler, P Kozlowski, B A Pappas, H de Socarraz, J K Saunders, M T Richard.   

Abstract

Young and aged rats were subjected to cerebrovascular insufficiency (CVI) for 3 and 9 weeks. At the end of each time period, local cerebral blood flow (lCBF), spatial memory function, 31P- and 1H-NMR spectroscopy and imaging of the brains were evaluated in vivo. Morphometric counts of CA1 hippocampal neuron damage and staining for glial fibrillary acidic protein (GFAP) were done post-mortem. Results show that after 3 weeks of CVI, cortical and hippocampal lCBF was significantly reduced in young and aged animals respectively. In addition, young and aged rats at 3 weeks following CVI showed spatial memory deficits in the Morris water maze and elevation of 31P-phosphomonoester as measured by non-invasive NMR spectroscopy. At the same time period, in vivo 1H-microimaging (MRI) of brains showed areas of high signal intensity (suggesting local edema) localized asymmetrically to the right hippocampal region in young and aged CVI rats. Morphometry of the hippocampal CA1 sector at post-mortem confirmed the in vivo MRI changes and demonstrated that a significant percentage of the CA1 pyramidal cells were damaged after CVI. Nine weeks after CVI, hippocampal CBF reductions, spatial memory impairment, spectroscopic-microimaging changes and CA1 sector cell damage continued to be observed in the aged animals but were resolved in the young rat brains. In addition, GFAP immunoreaction progressively increased in the hippocampus of aged rats subjected to CVI for 9 weeks. It is concluded that cognitive, metabolic and morphologic damage was significantly more severe and longer lasting in aged than young rat brain after chronic CVI. The deficits observed in this rat model appear to mimic the early pathology reported in Alzheimer's disease and suggest that the present model could provide fundamental clues relative to the etiology and possible management of this dementia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1327402     DOI: 10.1016/0006-8993(92)90132-s

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  38 in total

1.  Magnetization transfer measurements of the hippocampus in patients with Alzheimer's disease, vascular dementia, and other types of dementia.

Authors:  H Hanyu; T Asano; T Iwamoto; M Takasaki; H Shindo; K Abe
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

Review 2.  Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.

Authors:  Ernesto Solis; Kevin N Hascup; Erin R Hascup
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

3.  Age-dependent MRI-detected lesions at early stages of transient global ischemia in rat brain.

Authors:  R Canese; P Lorenzini; S Fortuna; M T Volpe; M Giannini; F Podo; H Michalek
Journal:  MAGMA       Date:  2004-12-21       Impact factor: 2.310

4.  Executive dysfunction and blockage of brain microvessels in a rat model of vascular cognitive impairment.

Authors:  Kristopher D Langdon; Chris A Cordova; Shirley Granter-Button; Jamie D Boyd; James Peeling; Timothy H Murphy; Dale Corbett
Journal:  J Cereb Blood Flow Metab       Date:  2017-10-30       Impact factor: 6.200

5.  Case report: regional cerebral hypoperfusion induced by ventricular tachycardia - short-term hippocampal hypoperfusion and its potential relationship to selective neuronal damage.

Authors:  A Hagendorff; E Klemm; M Bangard; C Dettmers; C Wolpert; B Schumacher; H J Biersack; F Grünwald; B Lüderitz; D Pfeiffer
Journal:  J Interv Card Electrophysiol       Date:  2001-12       Impact factor: 1.900

6.  Comparison of In Vivo and Ex Vivo MRI of the Human Hippocampal Formation in the Same Subjects.

Authors:  L E M Wisse; D H Adler; R Ittyerah; J B Pluta; J L Robinson; T Schuck; J Q Trojanowski; M Grossman; J A Detre; M A Elliott; J B Toledo; W Liu; S Pickup; S R Das; D A Wolk; P A Yushkevich
Journal:  Cereb Cortex       Date:  2017-11-01       Impact factor: 5.357

7.  Erythropoietin Rescues Memory Impairment in a Rat Model of Chronic Cerebral Hypoperfusion via the EPO-R/JAK2/STAT5/PI3K/Akt/GSK-3β Pathway.

Authors:  Shengli Ma; Juwu Chen; Chen Chen; Na Wei; Jingjing Xu; Guohui Yang; Nan Wang; Yu Meng; Jia Ren; Zongchao Xu
Journal:  Mol Neurobiol       Date:  2017-05-09       Impact factor: 5.590

Review 8.  The impact of cerebrovascular aging on vascular cognitive impairment and dementia.

Authors:  Tuo Yang; Yang Sun; Zhengyu Lu; Rehana K Leak; Feng Zhang
Journal:  Ageing Res Rev       Date:  2016-09-28       Impact factor: 10.895

Review 9.  In vivo NMR studies of neurodegenerative diseases in transgenic and rodent models.

Authors:  In-Young Choi; Sang-Pil Lee; David N Guilfoyle; Joseph A Helpern
Journal:  Neurochem Res       Date:  2003-07       Impact factor: 3.996

10.  Cognitive rehabilitation reduces cognitive impairment and normalizes hippocampal CA1 architecture in a rat model of vascular dementia.

Authors:  Kristopher D Langdon; Shirley Granter-Button; Carolyn W Harley; Frances Moody-Corbett; James Peeling; Dale Corbett
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-20       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.